Congress expands small-business R&D funding, mandates diversity outreach
S. 1573 — SBIR/STTR Reauthorization Act of 2025 · Filed by Ed Markey (D-MA) · 1 cosponsor · Introduced May 1, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes and expands the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through 2030, increasing the percentage of federal R&D budgets agencies must allocate to these programs (from current levels to 7% by 2032), and adding new requirements for fellowship programs, diversity outreach, commercialization support, and reporting on research institutions and technology transfer outcomes.
Why we flagged it
The bill's core mechanism is reauthorization and expansion of federal R&D funding set-asides for small businesses, with new diversity and commercialization requirements. It is a straightforward programmatic reauthorization with enhanced accountability measures.
What the text implies
- Section 505 codifies restrictions on SBIR participation by small businesses majority-owned by venture capital, hedge funds, or private equity firms if they are controlled by 'covered foreign entities'—this creates a national-security screening mechanism within the SBIR program that may affect startup funding structures.
- Section 506 (Commercialization Impact Assessment) requires tracking of 9-year revenue and employment outcomes for high-award recipients, creating a longitudinal dataset on SBIR/STTR ROI that could inform future program design or justify expansion/contraction.
- Section 504 (NIH Pilot) allows NIH to use alternative peer-review procedures and deem them compliant with Public Health Service Act requirements—this may reduce procedural rigor or create a precedent for other agencies to streamline review at the cost of consistency.
- Section 402 expands 'direct to Phase II' authority to all SBIR-participating agencies (not just NIH, DoD, Education) with a 10% cap (15% for NIH), potentially accelerating funding but reducing Phase I screening rigor across the federal R&D portfolio.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands federal R&D funding access for small businesses, with explicit mechanisms to increase participation by women, socially disadvantaged, and economically disadvantaged entrepreneurs, and underrepresented geographic regions. It also mandates commercialization support and transparency reporting, which benefits the broader public by accelerating technology transfer and economic opportunity.
Who stands to gain
- Small businesses participating in SBIR/STTR programs
- Women-owned small businesses
- Socially and economically disadvantaged small business owners
- Small businesses in underrepresented geographic regions
- Research institutions (universities, nonprofits, FFRDCs) subcontracted by SBIR/STTR awardees
- Third-party technical and business assistance vendors
- Nonprofit organizations providing outreach and fellowship support
Named in the bill
Small Business Administration (SBA), National Institutes of Health (NIH), Department of Defense (DoD), National Science Foundation (NSF), Department of Energy (DoE), Department of Health and Human Services (HHS), NASA, General Services Administration (GSA), Comptroller General of the United States, Minority institutions (as defined in Higher Education Act), Hispanic-serving institutions, Tribal Colleges and Universities — and 2 more
Where it stands
1 cosponsor: 1 Democrats.
- May 1, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- May 1, 2025 — Referred to Senate Committee on Small Business and Entrepreneurship · Congress.gov: “Read twice and referred to the Committee on Small Business and Entrepreneurship”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
11 lobbying clients named this bill on 29 disclosure filings across 6 quarters, Jun 2025 to Sep 2026. Those filings disclosed $8,386,820 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 90% of bills with at least one filing.
Ed Markey, the sponsor, reported $699,450 in PAC receipts in the 2026 cycle.
- Biotechnology Innovation Organization — $6,540,000 on 3 filings
- Association for Uncrewed Vehicle Systems International — $606,750 on 6 filings
- Association of American Universities — $460,070 on 3 filings
- Boston University — $220,000 on 4 filings
- Vanderbilt University — $220,000 on 1 filing
Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (44,481 characters) on Sep 27, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2025 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.
- S. 1573 on Congress.gov
- Actions and status history
- Cosponsors (1)
- Bill text the analysis read
- Biotechnology Innovation Organization — LDA filing, 2026 Q3
- Association for Uncrewed Vehicle Systems International — LDA filing, 2026 Q3
- Association of American Universities — LDA filing, 2025 Q4
- Ed Markey — FEC candidate receipts, 2026 cycle
“Congress expands small-business R&D funding, mandates diversity outreach” QuorumCivic. https://share.quorumcivic.app/bill/119/s1573 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.